It is no surprise that the US budget sequestration, which took effect in March and resulted in cuts to the funding of major federal government research agencies (see IBO 3/15/13), is affecting instrument and lab product company revenues. Based on comments made on recent quarterly conference calls of publicly held instrument and laboratory product companies, […]

Fourteen of the 17 companies in the IBO Laboratory Sales Index reported quarterly earnings before this issue’s publication. Including estimates for Analytik Jena (Analytical Instrumentation and Life Science) Spectris (Materials Analysis) and Tecan, third quarter revenue for the IBO Laboratory Sales Index grew 1.4%, 0.9% excluding currency, to $6,143 million. Operating profit improved 1.7% to […]

Company Announcements In August, Agilent Technologies gave an Agilent Thought Leader Award to Dr. Emmanuel Barillot, director of Bioinformatics and Systems IT at the Institute Curie in Paris, in recognition of his development of user friendly, Web-based bioinformatics tools for systems toxicology. Agilent Technologies opened in August the $25 million Spectroscopy Technology Innovation Center in […]

The dependence on Federal stimulus spending along with positive earnings and stronger-than-expected manufacturing data in China elevated US equity markets to new highs in October. The Federal Reserve maintained its bond buying policy citing sluggish employment growth. The probability of any policy change for the remainder of the year is extremely low due to weak […]

Enthusiasm has dampened for instrument and lab product sales growth in coming months, according to the annual fall IBO Business Climate Survey. Following a rebound in optimism this spring (see IBO 5/15/13), respondents are again moderating their expectations for sales growth over the next six months. More moderate expectations are also evident in the International […]

For the second quarter, revenues for IBO’s Laboratory Equipment/Consumables Sales Index grew 1.2%, 2.2% excluding currency, to $4,111 million. Operating profits for the Index rose 0.2% to $738 million. Based on continuing operations, operating margin slipped 30 basis points to 17.9% of sales. For the fiscal second quarter ending May 31, revenue for Gerresheimer’s Life […]

Company Announcements Roche Diagnostics’ second quarter sales of qPCR and NAP (nucleic acid purification) Systems increased 6%. Fiscal first quarter sales ending June 30 for Hitachi High-Technologies Science and Medical Systems (SMS) fell 18.0% to ¥29,100 million ($294.5 million) to account for 22% of revenues (see IBO 7/31/13). Biotechnology, Medical and Electron Microscopes declined 26.2%, […]

Despite concerns over the US debt ceiling and a potential government shutdown, equity markets advanced in September due to the Federal Reserve’s decision to continue its bond purchase program, as well as improving economic data, including higher personal income and spending. However, consumer sentiment shifted more negatively in September as a result of discouraging prospects […]